Abstract
C27-steroid 26-hydroxylase activity in fibroblasts from two heterozygotes for CTX was determined, using an optimized enzyme assay. With 5β-cholestane-3α, 7α, 12α-triol, 5β-cholestane-3α, 7α-diol, 7α-hydroxy-4-cholesten-3-one or 7α-hydroxycholesterol as substrates, the activities were about 50% of those of control cells. The Km for the substrates was not increased in the CTX heterozygotes. These findings support that deficiency of the C27-steroid 26-hydroxylase is the primary enzymatic defect in CTX.